Keyphrases
Drug Discovery
100%
Structure-activity Relationship
62%
Plasmodium Falciparum
57%
Medicinal Chemistry
49%
CGMP-dependent Protein Kinase
47%
Selective Serotonin Reuptake Inhibitors
43%
Phosphodiesterase
38%
Protein Kinase
38%
Diamine
35%
Phosphodiesterase Type 5 Inhibitors
35%
D2 Partial Agonist
34%
Schizophrenia Treatment
28%
Dopamine D2
28%
American Chemical Society
28%
National Conference
28%
1,2-Diaminocyclohexane
28%
Antitumor Properties
28%
Tropone
28%
Epigallocatechin Gallate
28%
Protein Kinase Inhibitors
28%
Sildenafil
26%
Methyl
26%
PDE
26%
Brugia Malayi
25%
Erectile Dysfunction
24%
Cell-based
24%
Organic Chemistry
23%
Malaria
22%
Potential Treatments
21%
PfPKG Inhibitor
21%
PDE Inhibitors
21%
Photocyclization
21%
HERG
21%
Structure-activity Studies
21%
Epoxides
21%
Regioselectivity
20%
Drug-like
20%
Stereochemistry
20%
CNS Disorders
20%
Pyrrol
19%
Antiparasitic
19%
Disubstituted
19%
Choline Acetyltransferase (ChAT)
19%
γ-butyrolactone
19%
New Drugs
19%
Book Series
19%
Drug Target Discovery
19%
Inhibitor Development
17%
Drug Candidates
17%
Esters
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
89%
Structure Activity Relationship
64%
Pharmaceutical Chemistry
54%
Partial Agonist
43%
Phosphodiesterase V Inhibitor
43%
Disease
40%
Phosphodiesterase
39%
Selective Serotonin Reuptake Inhibitor
35%
Serotonin Reuptake Inhibitor
35%
Cyclic GMP Dependent Protein Kinase
33%
Plasmodium falciparum
33%
Clinical Trial
29%
Receptor Agonist
28%
Leukemia P 388
28%
Calcium Sensing Receptor
28%
Receptor Antagonist
28%
K 252a
28%
Epoxide
28%
Sildenafil
27%
Brugia malayi
25%
Erectile Dysfunction
25%
Carbamic Acid
21%
Ethylene Oxide
21%
Cyclohexene Derivative
21%
Protein Kinases
21%
Antimalarial Agent
21%
Nematode
19%
Antiparasitic Activity
19%
Dopamine Receptor D2
19%
Choline Acetyltransferase
17%
Chronic Disease
17%
Serotonin
17%
Competitive Inhibitor
16%
Tropical Disease
16%
Antifilarial Agent
14%
Microfilaria (Nematode Larva)
14%
Histone Demethylase
14%
Wuchereria bancrofti
14%
Reuptake Inhibitor
14%
Neuroprotective Agent
14%
Anti-Inflammatory Drug
14%
Purinergic P2Y Receptor
14%
Receptor Antagonist
14%
Adenosine Receptor
14%
Carbazole Derivative
14%
Proteinase Activated Receptor 2
14%
Phosphodiesterase Inhibitor
14%
Antivirus Agent
14%
Imidazole
14%
Central Nervous System Disease
14%